Thromboembolic event rate in patients with persistent or paroxysmal atrial fibrillation post circumferential pulmonary vein isolation: A single center experience in China

Chinese Medical Journal

Volumn 120, Issue 11, 2007, Pages 956-959

  Zhou, Jing Min ^a   Liu, Shao Wen ^a   Lin, Jia Xiong ^a   Nie, Zhen Ning ^a   Wu, Hong Yi ^a   Zhou, Jun ^a   Hao, Ying ^a   Cai, Nai Sheng ^a   Ge, Jun Bo ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Atrial fibrillation; Catheter ablation; Thromboembolism; Thrombosis

Indexed keywords

AMIODARONE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; AGED; ARTICLE; CHINA; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT SAFETY; PULMONARY VEIN; RADIOFREQUENCY ABLATION; RISK ASSESSMENT; SURGICAL RISK; SURGICAL TECHNIQUE; THROMBOEMBOLISM; TREATMENT DURATION;

EID: 34250173112     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200706010-00003     Document Type: Article

References (17)

1. Oral H, Pappone C, Chugh A, Good E, Bogun F, Pelosi F, et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med 2006; 354: 934-941.
2. Thakur RK, Klein GJ, Yee R, Zardini M. Embolic complications after radiofrequency catheter ablation. Am J Cardiol 1994; 74: 278-279.
3. Kok LC, Mangrum JM, Haines DE, Mounsey JP. Cerebrovascular complication associated with pulmonary vein ablation. J Cardiovasc Electrophysiol 2002; 13: 764-767.
4. Liu SW, Yang YZ, Gao LJ, Li SH, Yin XM, Lin ZH. Anticoagulation therapy in patients with paroxysmal atrial fibrillation before and after the pulmonary vein isolation. Chin J Cardiac Pacing Electrophysiol (Chin) 2004; 18: 432-434.
5. Haissaguerre M, Jais P, Shah DC, Garrigue S, Takahashi A, Lavergne T, et al. Electrophysiological endpoint for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation 2000; 101: 1409-1417.
6. Oral H, Knight BP, Tada H, Ozaydin M, Chugh A, Hassan S, et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation 2002; 105: 1077-1081.
7. Pappone C, Rosanio S, Augello G, Gallus G, Vicedomini G, Mazzone P, et al. Mortality, morbidity and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol 2003; 42: 185-197.
8. Ren JF, Marchlinski FE, Callans DJ. Left atrial thrombus associated with ablation for atrial fibrillation: identification with intracardiac echocardiography. J Am Coll Cardiol 2004; 43: 1861-1867.
9. Maleki K, Mohammadi R, Hart D, Cotiga D, Farhat N, Steinberg JS. Intracardiac ultrasound detection of thrombus on transseptal sheath: incidence, treatment, and prevention. J Cardiovasc Electrophysiol 2005; 16: 561-565.
10. Wazni OM, Rossillo A, Marrouche NF, Saad EB, Martin DO, Bhargava M, et al. Embolic events and char formation during pulmonary vein isolation in patients with atrial fibrillation: impact of different anticoagulation regimens and importance of intracardiac echo imaging. J Cardiovasc Electrophysiol 2005; 16: 576-581.
11. Oral H, Chugh A, Good E, Sankaran S, Reich SS, Igic P, et al. A tailored approach to catheter ablation of paroxysmal atrial fibrillation. Circulation 2006; 113: 1824-1831.
12. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 2005; 111: 1100-1105.
13. Chen SA, Hsieh MH, Tai CT, Tsai CF, Prakash VS, Yu WC, et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 1999; 100: 1879-1886.
14. Haissaguerre M, Shah DC, Jais P, Hocini M, Yamane T. Deisenhofer I, et al. Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation 2000; 102: 2463-2465.
15. Marrouche NF, Dresing T, Cole C, Bash D, Saad E, Balaban K, et al. Circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation: impact of different catheter technologies. J Am Coll Cardiol 2002; 40: 464-474.
16. Oral H, Knight BP, Ozaydin M, Chugh A, Lai SW, Scharf C, et al. Segmental ostial ablation to isolate the pulmonary veins during atrial fibrillation: feasibility and mechanistic insights. Circulation 2002; 106: 1256-1262.
17. Oral H, Chugh A, Ozaydin M, Good E, Fortino J, Sankaran S, et al. Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation 2006; 114: 759-765.